A Look At FactSet Research Systems (FDS) Valuation After Earnings Beat And New AI Product Announcements

FactSet Research Systems Inc. +1.25%

FactSet Research Systems Inc.

FDS

227.68

+1.25%

FactSet Research Systems (FDS) has drawn fresh attention after a quarterly update that exceeded earnings expectations, along with new AI driven products and a Kepler Cheuvreux research partnership that deepen its data and workflow offering.

Despite the upbeat earnings and new AI focused products, the 30 day share price return of 28.69% and year to date share price return of 27.77% decline show momentum has been weak. The 1 year total shareholder return of 54.35% decline also points to a tougher period for long term holders.

If this AI push has caught your attention, it could be a good moment to see what else is happening across 57 profitable AI stocks that aren't just burning cash and compare other cash generating AI names on your watchlist.

With the shares trading at US$205.79 and sitting at a 36.13% discount to an estimated intrinsic value and around a 55.01% discount to analyst targets, you have to ask: is there a mispriced opportunity here, or is the market already bracing for slower growth?

Most Popular Narrative: 34.5% Undervalued

With FactSet Research Systems last closing at $205.79 against a narrative fair value of $313.99, the gap between market price and this view of worth is hard to ignore.

At the current price of ~210 USD, the market is valuing FactSet as a certain victim of generative AI (“SaaSPocalypse”), completely ignoring the company’s structural transformation over the last 5 years. FactSet no longer sells just access to stock prices (which can be commoditized); it sells operational infrastructure built on four strategic pillars that are extremely hard for a chatbot to replace: Cobalt (Private Markets), CUSIP (Global Standards), Vermilion (Reporting), and Portware (Execution).

Curious how a business built around private markets data, niche identifiers, reporting engines and execution platforms gets to that higher value? The projected mix of revenue growth, profitability, and future multiples in this narrative is anything but simple. Want to see which long term assumptions sit behind that gap to $313.99?

Result: Fair Value of $313.99 (UNDERVALUED)

However, this hinges on CUSIP, Portware, Vermilion and Cobalt keeping their grip on client workflows, and on AI tools not eroding pricing power or margins.

Build Your Own FactSet Research Systems Narrative

If you see the story differently or want to rely on your own work, you can quickly build a custom view in a few minutes using Do it your way.

A great starting point for your FactSet Research Systems research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

Once you have formed a view on FactSet Research Systems, do not stop there, broaden your opportunity set and pressure test your thinking against other stocks.

  • Target potential value opportunities by scanning 53 high quality undervalued stocks that combine earnings strength with prices that may not fully reflect their fundamentals.
  • Prioritise resilience with 84 resilient stocks with low risk scores if you want companies where our risk scoring points to steadier profiles.
  • Hunt for tomorrow’s standouts by checking our screener containing 23 high quality undiscovered gems and see which lesser known names meet solid quality checks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.